·   Log in

Archive for December 30th, 2009

India to buy 1.5 million doses of H1N1 swine flu vaccine from Sanofi Pasteur: Reports

Wednesday, December 30, 2009 21:47

Sanofi Pastuer recalled 800,000 pre-filled syringes of Influenza A (H1N1) 2009 Monovalent Vaccine for kids from US market on potency problems

This was posted under category: Biotech, Featured  |  Read Full Story  |  0 Comments

OTC lotion to treat cold sores NB-001 to enter US, Canada

Wednesday, December 30, 2009 19:51

NB-001, a novel topical over-the-counter (OTC) treatment for cold sores (herpes labialis), may soon hit the markets in US and Canada.

This was posted under category: Clinical Trials, Consumer  |  Read Full Story  |  0 Comments
Tagged with: ,

New epilepsy drug retigabine under FDA review in US

Wednesday, December 30, 2009 15:19

Retigabine, a new treatment for adult epilepsy patients with partial-onset seizures, has been accepted for review by US FDA.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments

Novo Nordisk’s diabetes drug liraglutide (Victoza) FDA approval delayed in US

Wednesday, December 30, 2009 13:57

Victoza could be a potential block-buster to treat diabetes and obesity if approved, believes Novo

This was posted under category: Industry  |  Read Full Story  |  1 Comment
Tagged with: , ,

STA-9090 highly promising in advanced gastrointestinal stromal tumours (GIST), says Synta

Wednesday, December 30, 2009 12:20

STA-9090, an experimental treatment against advanced gastrointestinal stromal tumours (GIST) has been shown encouraging results, according to Synta Pharmaceuticals Corp.

This was posted under category: Pharma  |  Read Full Story  |  0 Comments
Tagged with:

Ceftobiprole antibiotic to fight tougher bacterial infections fails to win approval in US

Wednesday, December 30, 2009 11:25

Ceftobiprole, a new antibiotic from Basilea Pharmaceutica to treat the tougher bugs like MSRA-resistant bacteria, has been rejected by USFDA.

This was posted under category: Clinical Trials  |  Read Full Story  |  1 Comment
Tagged with:

Pharmaxis’ lung function test Aridol rejected by US FDA

Wednesday, December 30, 2009 9:39

Aridol, an innovative lung function test by Pharmaxis, failed to win approval from US FDA which said that it needs more clinical data for approval.

This was posted under category: medical devices  |  Read Full Story  |  0 Comments
Tagged with: ,